rCBF SPECT in Parkinson’s disease patients with mental dysfunction

  • S. Bissessur
  • G. Tissingh
  • E. Ch. Wolters
  • Ph. Scheltens
Part of the Journal of Neural Transmission. Supplementa book series (NEURAL SUPPL, volume 50)


Functional imaging of the brain using SPECT provides information correlative to the alterations of regional blood flow. In this paper we review the literature pertaining to SPECT in Parkinson’s disease with and without dementia and depression. Parkinson’s disease itself is not associated with a consistent pattern of cerebral blood flow alterations in the basal ganglia, but reduced parietal blood flow is more often reported. The heterogeneity of blood flow changes possibly reflects the multifactorial pathophysiology of the disease. In demented Parkinson’s disease patients frontal hypoperfusion is often found or bilateral temporoparietal deficits, probably indicative of concommitant Alzheimer’s disease. The SPECT studies undertaken in depressed patients with and without Parkinsons’s disease show highly conflicting and inconsistent results, probably due to methodological and diagnostic flaws (especially the inclusion of demented Parkinson patients). Several lines of reasoning point to a prefrontal dysfunction and future SPECT studies are planned to study this region in non-demented Parkinson’s disease patients with and without major depression.


Single Photon emISSIOn Compute Tomography Regional Cerebral Blood Flow Single Photon emISSIOn Compute Tomography Study Mental Dysfunction Frontal Hypoperfusion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Baxter LR Jr, Schwartz JM, Phelps ME, et al (1989) Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry 46: 243–250PubMedCrossRefGoogle Scholar
  2. Baxter LR Jr, Phelps ME, Mazziotta JC, et al (1985) Cerebral metabolic rates for glucose in mood disorders: studies with positron emission tomography and fluorodeoxyglucose F18. Arch Gen Psychiatry 42: 441–447PubMedCrossRefGoogle Scholar
  3. Costa DC, Ell PJ, Burns A, Philpot M, Levy R (1988) CBF Tomograms with 99 Tc-HM-PAO in patients with dementia (Alzheimer type and HIV) and Parkinson’s disease — Initial results. J Cereb Blood Flow Metab 8: 109–115CrossRefGoogle Scholar
  4. De Jong BM, Van Royen EA (1989) Uptake of SPECT radiopharmaceuticals in neocortical brain cultures. Eur J Nucl Med 15: 16–20PubMedCrossRefGoogle Scholar
  5. Delvenne V, Delecluse F, Hubain Ph, et al (1990) Regional blood flow in patients with affective disorders. Br J Psychiatry 157: 359–365PubMedCrossRefGoogle Scholar
  6. Frackowiak RSJ, Gibbs JM (1983) Cerebral metabolism and blood flow in normal and pathological aging. In: PL Magistretti (ed) Functional Radionuclide Imaging of the Brain. Raven Press, New York, pp 305–309Google Scholar
  7. Gibb WRG (1994) Cortical dementia in Parkinson’s disease. In: Wolters EC, Scheltens P (eds) Mental dysfunction in Parkinson’s disease. Current issues in neurodegenerative disorders, vol 1. ICG Publications, Dordrecht, pp 211–221Google Scholar
  8. Globus M, Mildworf B, Melamed E (1985) Cerebral blood flow and cognitive impairment in Parkinson’s disease. Neurology 35: 1135–1139PubMedCrossRefGoogle Scholar
  9. Gur RE, Skolnick BE, Gur RC (1984) Brain functions in psychiatric disorders. II. Regional cerebral blood flow in medicated unipolar depressives. Arch Gen Psychiatry 41: 695–699PubMedCrossRefGoogle Scholar
  10. Henriksen L, Boas J (1985) Regional cerebral blood flow in hemiparkinson patients. Emission computerized tomography of inaled 133-Xenon before and after levodopa. Acta Neurol Scand 71: 257–266PubMedCrossRefGoogle Scholar
  11. Jagust WJ, Reed BR, Martin EM, Eberling JL, Nelson-Abbott RA (1992) Cognitivev function and regional cerebral blood flow in Parkinson’s disease. Brain 115: 521–537PubMedCrossRefGoogle Scholar
  12. Jolles JJ (1994) Brain and behavior mechanisms in depression. In: Wolters EC, Scheltens P (eds) Mental dysfunction in Parkinson’s disease. Current issues in neurodegenerative disorders, vol 1. ICG Publications, Dordrecht, pp 303–315Google Scholar
  13. Kuhl DE, Metter EJ, Riege WH (1984) Patterns of local cerebral glucose utilization determined in Parkinson’s disease by the 18F fluorodeoxyglucose method. Ann Neurol 15: 419–424PubMedCrossRefGoogle Scholar
  14. Kuhl DE, Metter EJ, Benson DF, et al (1985) Similarities of cerebral glucose metabolism in Alzheimer’s and parkinsonian dementia. J Cereb Blood Flow Metab 5 [Suppl 1]: S169Google Scholar
  15. Kuiper MA, Scheltens P, Weinstein HC, Wolters EC (1993) Dementia in Parkinson’s disease compared with Alzheimer’s type dementia. A [99mTc]HMPAO SPECT study. In: Nicolini M, Zatta PF, Corain B (eds) Alzheimer’s disease and related disorders. Pergamon Press, Oxford, pp 45–48Google Scholar
  16. Kuiper MA, Weinstein HC, Bergmans PLM, Scheltens P, Wolters EC (1992) [99mTc] HMPAO SPECT and dementia in Parkinson’s disease. J Neurol Neurosurg Psychiatry 55: 981PubMedCrossRefGoogle Scholar
  17. Kuniyoshi M, Arikawa K, Miura C, Inanaga K (1989) Parkinsonism manifesting with depression as the first sign. Jpn J Psychiatry Neurol 43: 37–43PubMedGoogle Scholar
  18. Lenzi GL, Jones T, Reid GL, Moss S (1979) Regional impairment of cerebral oxidative metabolism in Parkinson’s disease. J Neurol Neurosurg Psychiatry 22: 59–62CrossRefGoogle Scholar
  19. Lipsey JR, Robinson RG, Pearlson GD, et al (1983) Mood change following bilateral hemisphere brain injury. Br J Psychiatry 143: 266–273PubMedCrossRefGoogle Scholar
  20. Lishman WA (1968) Brain damage in relation to psychiatric disability after head injury. Br J Psychiatry 144: 373–410CrossRefGoogle Scholar
  21. Liu RS, Lin KN, Wang SJ, et al (1992) Cognition and [99mTc]HMPAO SPECT in Parkinson’s disease. Nucl Med Commun 13: 744–748PubMedGoogle Scholar
  22. Maes M, Dierckx R, Meltzer HY, et al (1993) Regional cerebral blood flow in unipolar depression measured with Tc-99m-HMPAO single photon emission computed tomography: negative findings. Psychiatry Res 50: 77–88PubMedCrossRefGoogle Scholar
  23. Martin WRW, Beckman JH, Calne DB, et al (1984) Cerebral glucose metabolism in Parkinson’s disease. Can J Neurol Sci 11: 169–173PubMedGoogle Scholar
  24. Mayberg HS, Jeffery PJ, Wagner HN, Simpson SG (1991) Regional cerebral blood flow in patients with refractory unipolar depression measured with Tc-99-HMPAO SPECT. J Nucl Med 32: S951Google Scholar
  25. Mayberg HS, Starkstein SE, Sadzot B, et al (1990) Selective hypometabolism in the inferior frontal lobe in depressed patients with Parkinson’s disease. Ann Neurol 28: 57–64PubMedCrossRefGoogle Scholar
  26. Neumann C, Baas H, Hefner R, Hör G (1989) SPECT-Befunde bei Hemiparkinson-Syndrom mit 99m Tc-HMPAO. Nucl Med 28: 92–94Google Scholar
  27. Pizzolato G, Dam M, Borsato N, et al (1988) [99mTc]HM-PAO SPECT in Parkinson’s disease. J Cereb Blood Flow Metab 8: S101–S108PubMedCrossRefGoogle Scholar
  28. Sackheim HA, Greenberg MS, Weinan Al, et al (1982) Hemispheric assymetry in the expression of positive and negative emotions. Arch Neurol 39: 210–218CrossRefGoogle Scholar
  29. Sawada H, Udaka F, Kameyama M, et al (1992) SPECT findings in Parkinson’s disease associated with dementia. J Neurol Neurosurg Psychiatry 55: 960–963PubMedCrossRefGoogle Scholar
  30. Spampinato U, Habert MO, Mas JL, et al (1991) [99mTc]HM-PAO SPECT and cognitive impairment in Parkinson’s disease: a comparison with dementia of the Alzheimer type. J Neurol Neurosurg Psychiatry 54: 787–792PubMedCrossRefGoogle Scholar
  31. Sperling R, Becker KA, Satlin A, Garada B, Holman BL, Growdon JH (1993) SPECT cerebral perfusion in neurodegenerative disease with dementia. Neurology 43 [Suppl]: A406CrossRefGoogle Scholar
  32. Tachibana H, Kawabata K, Tomino M, et al (1993) Brain perfusion imaging in Parkinson’s disease and Alzheimer’s disease demonstrated by three-demensional surface display with 1231-iodoamphetamine. Dementia 4: 334–341PubMedGoogle Scholar
  33. Tröster Al, Paolo AM, Lyons KE, Glatt SL, Hubble JP, Roller WC (1995) The influence of depression on cognition in Parkinson’s disease. Neurology 45: 672–676PubMedCrossRefGoogle Scholar
  34. Trzepac PT, Hertweck M, Starratt C, Zimmerman L, Adatepe MH (1992) The relationship of SPECT scans to behavioral dysfunction in neuropsychiatric patients. Psycho-somatics 33: 62–71Google Scholar
  35. Uytenhoef P, Portelange P, Jacquy J, et al (1983) Regional cerebral blood flow and lateralized hemispheric dysfunction in depression. Br J Psychiatry 143: 128–132CrossRefGoogle Scholar
  36. Van Praag HM (1994) Serotonin and affective psychopathology in parkinson’s disease. A psychobiological hypothesis with therapeutic consequences. In: Wolters EC, Scheltens P (eds) Mental dysfunction in Parkinson’s disease. Current issues in neurodegenerative disorders, vol 1. ICG Publications, Dordrecht, pp 335–351Google Scholar
  37. Wang S-J, Liu R-S, Liu H-S, et al (1993) Technetium-99m hexamethylpropylene amine oxime single photon emission tomography of the brain in early Parkinson’s disease: correlation with dementia and lateralization. Eur J Nucl Med 20: 339–344PubMedCrossRefGoogle Scholar
  38. Weinstein HC, Scheltens P, Van Royen EA, Hydra A (1993) Neuroimaging in the diagnosis of Alzheimer’s disease. II. Positron and single photon emission tomography (PET and SPECT). Clin Neurol Neurosurg 95: 81–91PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Wien 1997

Authors and Affiliations

  • S. Bissessur
    • 1
  • G. Tissingh
    • 1
  • E. Ch. Wolters
    • 1
  • Ph. Scheltens
    • 1
  1. 1.Department of NeurologyAcademisch Ziekenhuis VU AmsterdamAmsterdamThe Netherlands

Personalised recommendations